Literature DB >> 24975183

Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?

A Zaid, T Rinno, N Jaradat, S Jodeh, S Khammash.   

Abstract

The objective of this study was to evaluate the quality of 10 commercial paracetamol products available on the Palestinian market. We carried out a survey on the price of all paracetamol tablet products and assessed their quality. To assess quality, all products were examined visually for their organoleptic properties, tested for weight uniformity, friability, disintegration, and dissolution profile, and assayed for paracetamol content. All imported products were 2 to 3 times more expensive than the locally produced generic products. Based on our testing procedure, all paracetamol products were equivalent to the innovator product except for 1 imported product which fell below the approved specifications developed for the innovator product. Although the majority of generic products met the dissolution specification requirement that 80% of the drug must dissolve in 30 minutes, 1 generic product failed. These results demonstrate that generic paracetamol tablets produced by local manufacturers are often comparable in vitro to the innovator product and have lower costs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24975183

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  In-vitro Evaluations of Quality Control Parameters of Paracetamol Tablets Marketed in Gondar City, Northwest Ethiopia.

Authors:  Konjit Abebe; Tamirat Bekele Beressa; Bilal Tessema Yimer
Journal:  Drug Healthc Patient Saf       Date:  2020-12-21

2.  In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patients.

Authors:  Abdel Naser Zaid; Masshour Ghanem; Dua'a Shweiki; Hala Shtewi; Raja' Shaheen; Sondos Al Helaly; Zeina Khayyat; Rowa'a Al Ramahi; Sa'ed H Zyoud
Journal:  Ther Clin Risk Manag       Date:  2016-09-19       Impact factor: 2.423

3.  Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia.

Authors:  Reem AlSwayeh; Syed N Alvi; Muhammad M Hammami
Journal:  BMC Res Notes       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.